Thus, most symptoms in patients with SAS were observed in our mouse model with the deletion of Satb2 in the cerebral cortex and hippocampus at embryonic stages, and it may therefore serve as an animal model for studying the neurobiological mechanisms underlying SAS. This evidence concerns the gene SATB2 and SATB2 associated disorder.